YorkBridge Wealth Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$289K Sell
1,389
-65
-4% -$14.3K 0.07% 201
2022
Q3
$317K Sell
1,454
-120
-8% -$27.3K 0.08% 182
2022
Q2
$330K Buy
1,574
+8
+0.5% +$1.7K 0.09% 174
2022
Q1
$380K Sell
1,566
-66
-4% -$16K 0.08% 189
2021
Q4
$425K Buy
1,632
+56
+4% +$14.5K 0.1% 173
2021
Q3
$415K Buy
1,576
+65
+4% +$17.8K 0.1% 152
2021
Q2
$372K Buy
1,511
+40
+3% +$8.41K 0.1% 162
2021
Q1
$285K Buy
1,471
+495
+51% +$99.3K 0.08% 206
2020
Q4
$207K Buy
+976
New +$195K 0.07% 209
2019
Q3
Sell
-1,309
Closed -$160K 546
2019
Q2
$160K Sell
1,309
-6
-0.5% -$665 0.07% 211
2019
Q1
$137K Buy
1,315
+23
+2% +$2.37K 0.06% 229
2018
Q4
$147K Sell
1,292
-28
-2% -$3K 0.08% 183
2018
Q3
$152K Sell
1,320
-79
-6% -$8.65K 0.07% 207
2018
Q2
$145K Hold
1,399
0.06% 222
2018
Q1
$138K Sell
1,399
-9
-0.6% -$850 0.06% 229
2017
Q4
$131K Sell
1,408
-37
-3% -$3.06K 0.06% 231
2017
Q3
$111K Sell
1,445
-31
-2% -$2.37K 0.06% 253
2017
Q2
$115K Buy
1,476
+69
+5% +$4.94K 0.06% 246
2017
Q1
$98K Buy
1,407
+264
+23% +$18.2K 0.05% 267
2016
Q4
$67K Buy
+1,143
New +$70K 0.04% 309

Other funds holding RMD

YorkBridge Wealth Partners's RMD Position: Q4 2022 in Review

YorkBridge Wealth Partners reduced its ResMed (RMD) stake by 4.5% in Q4 2022, selling an estimated $14.3K and leaving 1,389 shares worth $289K. The position accounts for 0.07% of the portfolio, ranked #201.

YorkBridge Wealth Partners first reported a position in RMD in Q4 2016 and has held it in 20 quarters since. The position peaked at $425K in Q4 2021. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • YorkBridge Wealth Partners held 1,389 shares of ResMed worth $289K as of Q4 2022.
  • YorkBridge Wealth Partners sold 65 ResMed shares in Q4 2022, an estimated $14.3K.
  • ResMed made up 0.07% of YorkBridge Wealth Partners's portfolio in Q4 2022, its #201 holding.
  • YorkBridge Wealth Partners first reported a position in ResMed in Q4 2016 and has held it in 20 quarters since.
  • YorkBridge Wealth Partners's ResMed position peaked at $425K in Q4 2021.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.